Chen et al. demonstrated that TBK1 regulates malignant behaviors of bladder cancer cells via Akt signaling, providing novel insights into potential therapeutic targets for this disease (Chen et al., 2017). The gene discussed is AKT1; the disease is urinary bladder carcinoma.